| Characteristic | Minimum | Maximum |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
July 2024
Region
EU
Survey time period
2010 - 2022
Supplementary notes
* MDMA: methylenedioxymethamphetamine, ecstasy.
The figures were extracted from successive annual reports.
Citation formats








